| Dataset | NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles |
| Category | transcriptomics |
| Type | drug perturbation |
| Description | Dose=0.1uM, 3-((6-((5-Chloropyridin-2-yl)amino)pyrimidin-4-yl)amino)-4-(ethylsulfonyl)-N-methylbenzenesulfonamide, Tnni3 kinase inhibitor targeting TNNI3K (Novartis, 68304261) |
| External Link | https://pubchem.ncbi.nlm.nih.gov/compound/68304261 |
| Similar Terms | |
| Downloads & Tools |
1 genes differentially expressed following the BD-17-LT43_0.1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.
| Symbol | Name | Standardized Value |
|---|
| Symbol | Name | Standardized Value |
|---|---|---|
| USP21 | ubiquitin specific peptidase 21 | -0.361737 |